2 recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Recruiting 2 |
Follow Polypoidal Choroidal Vasculopathy (PCV): new trials by email Literature Review of Polypoidal Choroidal Vasculopathy (PCV) trials Research Report on Polypoidal Choroidal Vasculopathy (PCV)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prospective Trial of the Efficacy and Safety of a Personalized Regimen of High-dose Aflibercept 8mg on Treatment-naive Polypoidal Choroidal Vasculopathy: the PALLAS Trial aflibercept 8 mg - Polypoidal Choroidal Vasculopathy, Polypoidal Choroidal Vasculopathy (PCV) | Phase 3 | Recruiting | Yeungnam University College of Medicine | 50 | 2026-12-24 | 2026-02-05 |
| Efficacy and Durability of a Personalized Treat-and-extend Regimen of Faricimab for Treatment-naive Polypoidal Choroidal Vasculopathy Faricimab Injection [Vabysmo] - Polypoidal Choroidal Vasculopathy (PCV), Age Related Macular Degeneration | Phase 3 | Recruiting | Yeungnam University College of Medicine | 50 | 2026-03-01 | 2026-03-10 |
Polypoidal Choroidal Vasculopathy (2) · Macular Degeneration (1)
Choroid Diseases (2) · Choroidal Neovascularization (2) · Eye Diseases (2) · Metaplasia (2) · Neovascularization, Pathologic (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Uveal Diseases (2) · Retinal Degeneration (1) · Retinal Diseases (1)
aflibercept (1) · faricimab (1)
Yeungnam University College of Medicine (2)
South Korea (2)